KLTO - צמיחת הכנסות ב-12 חודשים נגררים Klotho Neurosciences

Klotho Neurosciences Inc (KLTO) is engaged in a venture battle for patents in the field of protecting the brain from degeneration. Margin stability is supported by a diversified network of laboratories and reliable biocomponent logistics. The GURU.Markets service features a linear chart of the annual growth in operating sales revenue (TTM), where the value 0.00 reflects the current figure, which depends on the success of preclinical tests and the attraction of investments.
פילוחי נתונים אנליטיים מרוכזים עבור anewmeds.com (KLTO)

This metric measures revenue dynamics over the last 12 months relative to the same period last year. It identifies fundamental shifts in the business by filtering out short-term market noise. For Klotho Neurosciences Inc (KLTO), this indicator reflects the commercial efficiency of its diversified portfolio of neurotherapeutic developments. Accelerating growth suggests a reduction in the startup's regulatory risks. By analyzing relative revenue growth over four quarters compared to the previous year, an investor can forecast the sustainability of the business model.